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Creating exact copies (clones) of an individual has long
been a made-to-believe story in various cultures through-
out mankind history. However, the report of successfully
creating a genetic clone of an adult animal from a differ-
entiated somatic cell [1] completely shocked the world.
The cloning technology involves taking the nucleus from
a somatic cell and then inserting that nucleus into an
unfertilized egg that has had its own nucleus removed.
The newly reconstructed embryo thus contains the entire
genetic makeup of the donor somatic cell (except for
mitochondria DNAs) and when transferred into the
uterus of a surrogate mother can develop into an individ-
ual genetically identical to the nuclear donor. Cloning via
nuclear transfer has succeeded in numerous mammalian
species involving the use of various somatic cells as
donors. These successes prove the principle that the
nucleus of a differentiated somatic cell from a variety of
adult tissues can be reprogrammed and converted to a
pluripotent embryo cell capable of giving rise to all cell
types, tissues and organs. While the technology of creating
replacement cells, tissues or organs from our own body
cells via nuclear transfer cloning (i.e., therapeutic cloning)
is very promising, the possibility of cloning a human via
this same technology (i.e., reproductive cloning) has cre-
ated various ethical concerns and regulation debate. Little
does the public realize that while the scientific commu-
nity strongly supports cloning animals for purposes of
agricultural improvement, biomedical research or saving
endangered species, they are absolutely opposed to clon-
ing a human being. The United Nations and all govern-
ments around the globe have called for a ban on
reproductive cloning in humans.
Unfortunately, the concerns about reproductive cloning
in humans have led many countries to ban any form of
cloning research in humans including therapeutic clon-
ing. Because of the great potential of the cloning technol-
ogy for potentially converting any somatic cell in our
body into a pluripotent embryonic cell capable of giving
rise to any desired cells, tissues or organs for replacement
therapy, the United Kingdom became the first country
with a policy supporting therapeutic cloning and permit-
ting government funding for this type of research. In con-
trast, the United States government is calling for a total
ban to any form of cloning research in humans. This ban
clearly will result in the loss for competition of the poten-
tial therapies and medical advances for the US market.
I firmly believe that the US government will lift this ban
within a few years because the US government and the
public will soon realize that the US risks losing its scien-
tific leadership as well as enormous economic and human
health benefits of this unprecedented revolution in
human health care and medicine. In order to comply with
the current US government policy and regulations, we are
currently focusing for now our research on therapeutic
cloning and regenerative research in animal models. A few
years from now, when the US government removes the
restrictions on therapeutic cloning research, we will be
fully prepared.
I have been an active member of the cloning research
community since 1983, initially studying embryonic cell
cloning. In collaboration with Dr. Chikara Kubota, we
cloned a 17-year-old prize breeding bull in Japan using
ear skin cells in 1998, only just over a year after the report
of Dolly's birth. This places us among the first groups to
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successfully clone adult cattle in the world. This work was
published in the Proceedings of the National Academy of
Sciences [2], entitled "Six cloned calves produced from
adult fibroblast cells after long-term culture". This signifi-
cant publication was recognized with a commentary enti-
tled "How close are we to implementing gene targeting in
animals other than the mouse", by Mario Capecchi, a pio-
neer of gene targeting research, in the same issue of PNAS
[3]. In June 1999, we reported the birth of Amy, the
cloned calf, which marked as the first clone (cow) from an
adult farm animal in the United States. Subsequently,
among other studies, we reported that the telomere
lengths in cloned calves are as normal as those from natu-
ral reproduction [4] and that abnormal expression of X-
linked genes in cloned animals may contribute to their
frequent abortions or neonatal death [5]. These achieve-
ments have caused a media sensation around the globe
including coverage by the CNN Headline News, The New
York Times, The Washington Post, The Wall Street Journal
and US News & World Report. Our high-profile achieve-
ments have helped me to realize my dream for building a
team for animal-model therapeutic cloning and stem cell
research at the University of Connecticut.
In 2001, a visionary project to build a Center of Excellence
to study into therapeutic cloning and stem cells was
approved and instituted by the University of Connecticut
and I was put in charge for recruiting five new faculty
members with complementary expertise to add to our
existing strong embryo development and biotechnology
expertise. I am very pleased to announce that we have suc-
cessfully recruited five outstanding scientists with the
desired complementary expertise as our Center core fac-
ulty members. A recent scientific symposium entitled
"First New England Symposium on Regenerative Biology
and Medicine" was held in Connecticut to commemorate
the founding of the University of Connecticut Center for
Regenerative Biology http://www.crb.uconn.edu. The
Associated Press (Donna Tommelleo, 2003-09-14) and
the New York Times (Marc Santora 2003-09-17) both
reported on this symposium along with other news
media. US Senator Christopher Dodd (D-Connecticut)
praised our research at our Center's dedication ceremony,
"This is important, not only for the university, but the
human condition". He further commented, "They are
doing research here that will make the world a better
place." (Robert Miller, The News Times 2003-09-16).
I am particularly pleased that the journal Reproductive
Biology and Endocrinology has dedicated this special
issue on Regenerative Biology to our new Center. I take
great pride and pleasure in introducing our readers to our
five talented new faculty members and briefly describing
the complementary expertise they have brought to the
University of Connecticut Center for Regenerative Biol-
ogy.
One of the challenges we face, and a potential bottleneck
for the successful application of the cloning technology is
its low efficiency. This is due to a high rate of embryonic
losses and abortions throughout the gestation period,
high rates of neonatal death as well as other abnormalities
after birth. Dr. X. Cindy Tian was recruited to the Center
as a molecular embryologist and geneticist to address
these issues by studying genetic programming using spe-
cific candidate genes as well as gene expression globally.
Specifically, Dr. Tian studies the process of gene repro-
gramming by somatic nuclear transfer. Since the creation
of Dolly, the first mammal cloned from an adult differen-
tiated somatic cell, a long-held dogma in developmental
biology, that the process of genes inactivation during
development and differentiation was irreversible, was rev-
olutionized. We now believe that inactivated genes can be
reactivated by the somatic cloning technology and are
capable to direct development of a new individual. The
process of gene reactivation by somatic nuclear transfer is
called nuclear or gene reprogramming. Nuclear repro-
gramming is the fundamental basis for tissue regeneration
by the stem cell technology. The high rates of develop-
mental abnormality of somatic clones, however, point to
the fact that the nuclear reprogramming process is incom-
plete and imperfect at this time. Understanding the mech-
anisms regulating the nuclear/gene reprogramming events
will lead to technologies for targeted re-differentiation of
cells for cell/tissue regeneration. In this special issue, Tian
et al [6] provide an overview on the state-of-the-art for
cloning research and challenges. This article complements
to a parallel paper by Tian [7] to review molecular
approaches to address these challenges.
An important and essential component of therapeutic
cloning is the capability to establish, characterize and dif-
ferentiate stem cells from the somatic cell-derived cloned
embryos. Dr. Joanne Conover was recruited to the Center
as an expert in stem cell biology. Dr. Conover's laboratory
offers expertise in mouse embryonic stem cell derivation
and characterization, as well as various differentiation
analyses. Specifically, Dr. Conover is interested in under-
standing two developmental pathways, one that instructs
stem cells to form dopaminergic neurons (those lost in
Parkinson's Disease) and another that instructs stem cells
to generate pancreatic islet cells (those lost in Type I Dia-
betes). A better understanding of these pathways will
allow researchers to reliably obtain specific cell types for
therapeutic use. Dr. Conover also has extensive experience
in studying adult neural stem cells and is interested in the
potential application of these cells toward the under-
standing and treatment of neurodegenerative diseases.
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Conover is interested in comparing derivation, differenti-
ation, and signaling pathways of different stem cell popu-
lations. Dr. Conover's research further extends to the
study of mechanisms involved in stem cell activation and
differentiation during regeneration. In this special issue,
Conover et al [8] discuss the fate of adult neural stem cells
in the adult brain and the molecular mechanisms that reg-
ulate adult neurogenesis in mice.
What makes a stem cell a stem cell and how stem cells dif-
ferentiate into various cell types remain mysteries in biol-
ogy. Dr. Theodore Rasmussen was recruited to the Center
as a cellular and molecular geneticist to study the mecha-
nisms of stem cell maintenance and differentiation. Spe-
cifically, Dr. Rasmussen's research concerning the
molecular mechanisms that govern differentiation proc-
esses will further the goal of achieving highly efficient and
rationally-guided differentiation. Chromatin proteins are
a diverse set of molecules that associate with DNA and
regulate gene expression in a tissue-specific manner.
Recent evidence suggests that chromatin proteins and
chromatin remodeling activities play a substantial role in
stem cell differentiation processes. This proposition is
supported by research into the mechanisms of X chromo-
some inactivation (one of the earliest developmental
changes in differentiating ES cells) and nuclear transfer
(cloning) experiments that suggest that "reprogramming"
may have its basis in chromatin remodeling. The Rasmus-
sen laboratory studies chromatin dynamics in mouse
embryonic stem (ES) cells as a model system to under-
stand differentiation processes on a mechanistic level. Dr.
Rasmussen is currently conducting extensive research on
macroH2A1, a specialized histone variant involved in
gene silencing and X inactivation. MacroH2A1 seems to
be a general component of heterochromatin and is incor-
porated into the inactive X chromosome of female ES cells
during the course of differentiation. In addition, Dr. Ras-
mussen is interested in the mechanisms that target the for-
mation of specialized chromatin to particular genomic
sites. In this special issue, Dr. Rasmussen [9] provides an
excellent overview on the recent advances in the under-
standing of the mechanisms that govern epigenetic regu-
lation of gene expression of stem cell maintenance and
differentiation dynamics. As embryonic cells differentiate,
certain genes are activated while others are silenced. These
activation and silencing events, which are exquisitely
coordinated with the allocation of cell lineages, are
reviewed in this article.
Understanding gene expression and regulation during
natural organogenesis and tissue differentiation obviously
will provide the theoretical basis to study in vitro stem cell
differentiation and tissue regeneration. Dr. David Gold-
hamer was recruited to the Center as a developmental
biologist to study fundamental mechanisms of skeletal
muscle development, growth and repair, with an empha-
sis on regulation of cell commitment and muscle-specific
gene expression. One long-term goal of the Goldhamer
laboratory is to define the genetic pathways that culmi-
nate in the activation of muscle regulatory factors in mus-
cle precursor cells during development, an understanding
of which will provide insight into how embryonic cells
choose between alternative cell fates during development.
A second major research area of his laboratory focuses on
the biology of stem cells resident in muscle tissue. Follow-
ing injury of adult skeletal muscle, or in diseases such as
Duchenne muscular dystrophy, skeletal muscle undergoes
a regenerative process that in many ways resembles mus-
cle development in the embryo. Skeletal muscle's enor-
mous regenerative capacity is mediated by muscle satellite
cells, normally quiescent stem cells that are "activated" in
response to injury or disease. Despite their essential func-
tion, key aspects of satellite cell biology remain unre-
solved, including their developmental origin, potential
and regulation of commitment to myogenesis. Dr. Gold-
hamer's recent research focuses on the use of cell marking
experiments and mouse genetics to investigate these fun-
damental aspects of satellite cell biology. Recent evidence
indicates that additional types of stem cells also exist in
skeletal muscle tissue, the identification of which is essen-
tial for understanding diseases of abnormal bone forma-
tion and for developing therapies for musculoskeletal
diseases. Characterization of this stem cell population and
its relationship to muscle satellite cells is also being pur-
sued in the Goldhamer laboratory. In this special issue,
Chen and Goldhamer [10] focus their review on the basic
biology of the satellite cell with emphasis on its role in
muscle repair and parallels between embryonic myogene-
sis and muscle regeneration. The relationship between the
satellite cell and other newly discovered muscle stem cell
populations is also discussed. The authors conclude with
advances and prospects for cell-based therapies for mus-
cular dystrophies.
Successful application of therapeutic cloning and regener-
ation requires critical expertise in cell/tissue engineering
and transplantation biology. Dr. William Fodor was
recruited to the Center to provide this critical expertise.
Specifically, the goal of the Fodor laboratory is to develop
genetically engineered cells and tissues to repair, restore
and regenerate lost tissues due to disease and injury. Dr.
Fodor's research efforts span many disciplines including,
immunology, molecular biology, neurobiology, trans-
genic technology, enzymology, and transplantation.
Additional research interests of his laboratory include
developing molecules that modulate the immune system,
cloning molecules involved in cytokine responses, and
investigating growth factors and immune mechanisms
responsible for cell survival and engraftment in various
transplant models. In this special issue, the Fodor paperPublish with BioMed Central    and   every 
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[11] will provide an overview of recent advances in the
development of cells, tissues and organs for the purpose
of restoring function through transplantation. This review
will also address some of the hurdles yet to be overcome
as the technology and science improve the likelihood that
Regenerative Medicine will become clinically routine.
In this special issue, two additional reviews were included.
Xu and Yang [12] provide a comprehensive review of the
controversial issues surrounding the genetic age of clones
with a focus on the telomere debate and how telomeres
are related to the ageing problems of clones. Wang and
Zhou [13] review the possibility and reality of gene target-
ing of somatic cells followed by cloning in farm animals.
In this review, the principles of gene targeting in somatic
cells and the challenges of nuclear transfer using gene-tar-
geted cells, are discussed. The relevance and potential
impact of gene targeting in domestic animals for applica-
tions in bio-medicine and agriculture are also examined.
Finally, it has been a privilege to edit this special issue of
"Regenerative Biology" on behalf of Reproductive Biology
and Endocrinology. I would like to thank the Editor-in-
Chief, Professor Antonin Bukovsky for the kind invita-
tion, advice and guidance throughout the preparation of
this special issue. I would also like to thank President
Philip Austin, Provost and Executive Vice President John
Petersen and the other senior administrators at the Uni-
versity of Connecticut for helping to make my dream
come true for building this Center of excellence. A special
note of thanks goes to Dr. Ian Hart, Professor, Associate
Dean for Research of the College of Agriculture and Natu-
ral Resources, for recruiting me to UConn and for his per-
sistent support to my career development at the
University. Let me take this opportunity to thank all guest
speakers at our Center's recent dedication symposium:
Drs. James Battey of NIH, Charles Jennings, Gerald Schat-
ten, Mark Mirando, Harris Lewin, Jean-Paul Renard, Rob-
ert Wall, Marc Lalande, Gerry Berkowitz, Tim Hla, Eugene
Chen, Alex Lichtler and David Reisner. Susan Ayers,
Rafaela Rivera, Wendy Zhou, May Liu and the many hard-
working graduate and undergraduate students and
research associates for doing an excellent job to ensure the
success of our dedication symposium. Finally, a special
thank you to Marina Julian who has served me very well
as my assistant guest editor for this very special issue of
Regenerative Biology.
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